CD44 and familial pancreatic carcinoma: The extract also inhibited CD44+/CD24+/EpCAMhigh pancreatic cancer stem cell (CSC) populations, CSC-associated markers SOX2, OCT4, NANOG and CD44 in-vitro and in-vivo, and increased sensitivity to gemcitabine [57].